NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Helaina

Helaina

Private
New York City, New YorkHealthcare & Life Scienceshttps://www.myhelaina.com/

Last Round

Early Funding

Jun 2, 2026

Est. Valuation

$65M

Total Funding Raised

$74.01M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Helaina is a biotechnology company that produces human-equivalent bioactive proteins through precision fermentation for use in nutritional products.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Advanced Materials, Smart Manufacturing

Business Model

B2B2C

Customer Profile

Services & Consulting

AI Layer

Application

Keywords

precision fermentationhuman lactoferrinbioactive proteinsinfant nutritionbreast milk proteinfood techinfant formulaingredient supplierrecombinant proteinalternative proteinsfood ingredientssynthetic biologysynbiofunctional foodsdietary supplementsbiomanufacturing

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Helaina Comparables

Compare Helaina with similar companies based on industry and business-model similarity.

Helaina comparables — related companies by embedding similarity
CompanySimilarityMarket Cap

View Full Comparables Set

Access detailed peer comparisons, similarity scores, and market data.

Helaina Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Early FundingJun 2, 2026
Series BSep 25, 2024
Series ANov 19, 2021
SeedAug 31, 2020

Key People

Founding team and executive leadership

Laura Katz

Founder CEO

Founding Team

Anthony Clark

Chief Technology Officer

Executive Team

Helaina Investors

Notable investors and investment history

Helaina investors
InvestorRounds
Siam CapitalSeries A, Series B
Relish WorksSeries B
Plum Alley InvestmentsSeries A
Avidity PartnersSeries B
Spark CapitalSeries B, Series A
Barrel VenturesSeries B, Series A, Seed
Ingeborg InvestmentsSeries B

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jun 2, 2026

    Raised $12M in early funding.

  • Mar 1, 2026

    Effera™, an identical replica of human lactoferrin, has been launched.

Helaina Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Helaina Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Helaina's valuation, stock price, and market status.

Firmographic Details

HeadquartersNew York City, New York
Employee Range51
Year Founded2019
Last FundingJun 2, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.